iSpecimen Inc (NASDAQ:ISPC) — Market Cap & Net Worth
Market Cap & Net Worth: iSpecimen Inc (ISPC)
iSpecimen Inc (NASDAQ:ISPC) has a market capitalization of $4.07 Million ($4.07 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28964 globally and #5868 in its home market, demonstrating a -6.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying iSpecimen Inc's stock price $2.83 by its total outstanding shares 1437157 (1.44 Million). Review ISPC total liabilities to assess the company's total debt and financial obligations.
iSpecimen Inc Market Cap History: 2021 to 2026
iSpecimen Inc's market capitalization history from 2021 to 2026. Data shows change from $224.48 Million to $4.07 Million (-54.39% CAGR).
Index Memberships
iSpecimen Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 0.00% | #857 of 976 |
|
NASDAQ Composite
IXIC
|
$41.39 Trillion | 0.00% | #2723 of 3165 |
Weight: iSpecimen Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
iSpecimen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how iSpecimen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.19x
iSpecimen Inc's market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $224.48 Million | $11.14 Million | -$8.96 Million | 20.16x | N/A |
| 2022 | $39.52 Million | $10.40 Million | -$10.25 Million | 3.80x | N/A |
| 2023 | $14.40 Million | $9.93 Million | -$11.10 Million | 1.45x | N/A |
| 2024 | $3.82 Million | $9.29 Million | -$12.50 Million | 0.41x | N/A |
| 2025 | $373.80K | $1.93 Million | -$10.49 Million | 0.19x | N/A |
Competitor Companies of ISPC by Market Capitalization
Companies near iSpecimen Inc in the global market cap rankings as of June 17, 2026.
Key companies related to iSpecimen Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.98 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #181 globally with a market cap of $127.92 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #622 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #662 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.98 Billion | $473.72 |
| #181 | Danaher Corporation | NYSE:DHR | $127.92 Billion | $181.10 |
| #622 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $570.00 |
| #662 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
iSpecimen Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, iSpecimen Inc's market cap moved from $224.48 Million to $ 4.07 Million, with a yearly change of -54.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.07 Million | +988.04% |
| 2025 | $373.80K | -90.20% |
| 2024 | $3.82 Million | -73.50% |
| 2023 | $14.40 Million | -63.56% |
| 2022 | $39.52 Million | -82.39% |
| 2021 | $224.48 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of iSpecimen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.07 Million USD |
| MoneyControl | $4.07 Million USD |
| MarketWatch | $4.07 Million USD |
| marketcap.company | $4.07 Million USD |
| Reuters | $4.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About iSpecimen Inc
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have ac… Read more